Market by Product and Service, Type, Application, Technology, Industry Vertical, and Country Outlook | Forecast 2024-2032
According to Triton’s research report, the Middle East and Africa multiplex assay market is estimated to progress with a compound annual growth rate of 7.83% over the forecasting period 2024-2032.
Report scope can be customized per your requirements - Request Free Sample Report
The countries in this region include:
• United Arab Emirates
• Turkey
• Saudi Arabia
• South Africa
• Rest of the Middle East & Africa
The Middle East and Africa multiplex assay market is primarily fueled by two factors: growing governmental collaboration to advance personalized medicine and escalating instances of breast cancer. Collaborative efforts among institutions to enhance personalized medicine promise lucrative prospects for multiplex assay deployment. Additionally, rising incidences of virulent diseases, a heightened need for detecting new biomarkers for prevailing viral infections, and increased R&D endeavors for drug improvement and biomarker detection also play significant roles in driving market expansion.
Saudi Arabia captures the highest market share in the region. Saudi Arabia is dealing with a rising prevalence of chronic diseases such as diabetes, cardiovascular conditions, and cancer. The adoption of multiplex assays presents an effective means of diagnosing these ailments accurately, thereby driving up the market’s growth. In addition, Noncommunicable diseases (NCDs) represent a substantial obstacle to the healthcare infrastructure. The surge of these chronic conditions thus widens the overall scope of the multiplex assay market.
The demographic landscape of the United Arab Emirates is shifting towards an aging population. Projections suggest a notable increase, with expectations that individuals aged 65 and above will constitute around 16% of the population by 2050. With age comes increased vulnerability to chronic ailments such as diabetes, cancer, and cardiovascular diseases. In this regard, multiplex assay emerges as an effective solution to manage these conditions, which creates lucrative opportunities for players in the multiplex assay market.
Historically, diseases like gastrointestinal infections, cardiovascular diseases, and cancer have been diagnosed through single-plex assays. However, multiplex assays offer distinct advantages over conventional methods. They require less sample volume, boast high throughput, and exhibit superior infection detection capabilities. Moreover, they’re increasingly being adopted for simultaneously detecting multiple analytes in a single test.
The market’s growth is determined based on application, type, industry vertical, product and service, and technology. In terms of application, it includes clinical diagnostics, research and development, and companion diagnostics.
The major enterprises in the market include Illumina Inc, Olink Proteomics AB, Randox Laboratories Ltd, Merck Millipore, and Qiagen NV.
Illumina Inc operates globally, specializing in developing, manufacturing, and distributing products and solutions for various life science applications. Its primary markets are clinical genomics and life sciences. The company provides a diverse range of products facilitating advanced disease research, drug development, and molecular tests. Its clientele includes pharmaceutical firms, academic institutions, clinical research organizations, etc. Illumina reaches its customers through direct sales and a network of distributors spanning multiple regions, including the Middle East and Africa.
KEY DELIVERABLES OF THE REPORT:
Market CAGR during the forecasting years 2024-2032
Detailed data highlighting key insights, industry components, and market strategies
Comprehensive information and estimation of the multiplex assay market revenue growth in the Middle East and Africa and its influence on the parent market
In-depth study of forthcoming trends in consumer behavioral patterns
A meticulous analysis of the competitive landscape and Porter’s Five Forces
A wide-ranging study of factors that will challenge the Middle East and Africa multiplex assay market’s growth during the upcoming years
Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MIDDLE
EAST AND AFRICA MULTIPLEX ASSAY MARKET- SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE MULTIPLEX ASSAY MARKET
2.1.1. IMPACT
OF COVID-19 ON THE MULTIPLEX ASSAY MARKET
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. COMPETITIVE
RIVALRY
2.3. KEY
BUYING IMPACT ANALYSIS
2.3.1. ANALYTE
COVERAGE
2.3.2. SPEED
2.3.3. MULTIPLEXING
CAPABILITY
2.3.4. EASE
OF USE
2.3.5. AUTOMATION
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. KEY
MARKET STRATEGIES
2.5.1. CONTRACTS
AND PARTNERSHIPS
2.5.2. BUSINESS
EXPANSIONS & DIVESTITURES
2.5.3. ACQUISITIONS
& MERGERS
2.5.4. PRODUCT
LAUNCHES & DEVELOPMENTS
2.6. MARKET
DRIVERS
2.6.1. ADOPTION
OF PERSONALIZED MEDICINES
2.6.2. HIGH
ADOPTION OF MULTIPLEX ASSAYS OVER TRADITIONAL METHODS
2.6.3. INCREASING
PREVALENCE OF CHRONIC DISEASES
2.7. MARKET
CHALLENGES
2.7.1. ISSUES
RELATED TO CROSS-REACTIVITY AND ASSAY INTERFERENCE
2.7.2. CHALLENGE
IN ACHIEVING ADEQUATE ASSAY RANGE
2.7.3. DEARTH
OF SKILLED PROFESSIONALS
2.8. MARKET
OPPORTUNITIES
2.8.1. TECHNOLOGICAL
ADVANCEMENTS IN ASSAY PLATFORMS
2.8.2. RAPID
GROWTH OF COMPANION DIAGNOSTICS
2.8.3. GROWTH
IN DRUG DISCOVERY INITIATIVES
2.9. ANALYST
PERSPECTIVE
3. MIDDLE
EAST AND AFRICA MULTIPLEX ASSAY MARKET - BY PRODUCT AND SERVICE
3.1. REAGENTS
AND CONSUMABLES
3.2. INSTRUMENTS
AND ACCESSORIES
3.3. SOFTWARE
AND SERVICES
4. MIDDLE
EAST AND AFRICA MULTIPLEX ASSAY MARKET - BY TYPE
4.1. PROTEIN-BASED
MULTIPLEX ASSAY
4.2. NUCLEIC
ACID-BASED MULTIPLEX ASSAY
4.3. OTHER
MULTIPLEX ASSAYS
5. MIDDLE
EAST AND AFRICA MULTIPLEX ASSAY MARKET - BY APPLICATION
5.1. RESEARCH
AND DEVELOPMENT
5.2. CLINICAL
DIAGNOSTICS
5.3. COMPANION
DIAGNOSTICS
6. MIDDLE
EAST AND AFRICA MULTIPLEX ASSAY MARKET - BY TECHNOLOGY
6.1. MULTIPLEX
PROTEIN MICROARRAY
6.2. MULTIPLEX
PCR
6.3. OTHER
TECHNOLOGIES
7. MIDDLE
EAST AND AFRICA MULTIPLEX ASSAY MARKET - BY INDUSTRY VERTICAL
7.1. PHARMACEUTICAL
& BIOTECHNOLOGY COMPANIES
7.2. RESEARCH
INSTITUTES
7.3. CLINICAL
LABORATORIES
7.4. HOSPITALS
8. MIDDLE
EAST AND AFRICA MULTIPLEX ASSAY MARKET – BY COUNTRY OUTLOOK
8.1. UNITED
ARAB EMIRATES
8.1.1. UNITED
ARAB EMIRATES MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.2. SAUDI
ARABIA
8.2.1. SAUDI
ARABIA MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.3. TURKEY
8.3.1. TURKEY
MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.4. SOUTH
AFRICA
8.4.1. SOUTH
AFRICA MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.5. REST
OF MIDDLE EAST & AFRICA
8.5.1. REST
OF MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
9. COMPETITIVE
LANDSCAPE
9.1. ABCAM
LIMITED
9.1.1. OVERVIEW
9.1.2. PRODUCT
PORTFOLIO
9.2. AGILENT
TECHNOLOGIES INC
9.2.1. OVERVIEW
9.2.2. PRODUCT
PORTFOLIO
9.2.3. KEY
STRENGTHS
9.2.4. KEY
CHALLENGES
9.3. BECTON
DICKINSON AND COMPANY (BD)
9.3.1. OVERVIEW
9.3.2. PRODUCT
PORTFOLIO
9.3.3. KEY
STRENGTHS
9.3.4. KEY
CHALLENGES
9.4. BIO-RAD
LABORATORIES INC
9.4.1. OVERVIEW
9.4.2. PRODUCT
PORTFOLIO
9.4.3. KEY
STRENGTHS
9.4.4. KEY
CHALLENGES
9.5. BIO-TECHNE
CORPORATION
9.5.1. OVERVIEW
9.5.2. PRODUCT
PORTFOLIO
9.6. F.
HOFFMANN-LA ROCHE LTD
9.6.1. OVERVIEW
9.6.2. PRODUCT
PORTFOLIO
9.6.3. KEY STRENGTHS
9.6.4. KEY CHALLENGES
9.7. ILLUMINA
INC
9.7.1. OVERVIEW
9.7.2. PRODUCT
PORTFOLIO
9.7.3. KEY STRENGTHS
9.7.4. KEY CHALLENGES
9.8. MERCK MILLIPORE
9.8.1. OVERVIEW
9.8.2. PRODUCT
PORTFOLIO
9.9. OLINK
PROTEOMICS AB
9.9.1. OVERVIEW
9.9.2. PRODUCT
PORTFOLIO
9.10. QIAGEN
NV
9.10.1. OVERVIEW
9.10.2. PRODUCT
PORTFOLIO
9.10.3. KEY STRENGTHS
9.10.4. KEY CHALLENGES
9.11. RANDOX
LABORATORIES LTD
9.11.1. OVERVIEW
9.11.2. PRODUCT
PORTFOLIO
9.12. SEEGENE
INC
9.12.1. OVERVIEW
9.12.2. PRODUCT
PORTFOLIO
9.13. SIEMENS
HEALTHINEERS AG
9.13.1. OVERVIEW
9.13.2. PRODUCT
PORTFOLIO
9.13.3. KEY
STRENGTHS
9.13.4. KEY
CHALLENGES
9.14. THERMO
FISHER SCIENTIFIC INC
9.14.1. OVERVIEW
9.14.2. PRODUCT
PORTFOLIO
9.14.3. KEY
STRENGTHS
9.14.4. KEY
CHALLENGES
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.2. SOURCES
OF DATA
10.3. RESEARCH
METHODOLOGY
TABLE
1: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK,
HISTORICAL YEARS, 2020-2023 (IN $ MILLION)
TABLE
2: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, FORECAST
YEARS, 2024-2032 (IN $ MILLION)
TABLE
3: CONTRACTS AND PARTNERSHIPS
TABLE
4: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
TABLE
5: ACQUISITIONS & MERGERS
TABLE
6: LIST OF NEW PRODUCT LAUNCHES & DEVELOPMENTS
TABLE
7: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE,
2024-2032 (IN $ MILLION)
TABLE
8: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY TYPE, 2024-2032 (IN $
MILLION)
TABLE
9: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2024-2032,
(IN $ MILLION)
TABLE
10: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2024-2032 (IN
$ MILLION)
TABLE
11: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICAL,
2024-2032 (IN $ MILLION)
TABLE
12: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK,
2024-2032 (IN $ MILLION)
FIGURE
1: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2023
& 2032 (IN %)
FIGURE
2: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES,
2024-2032 (IN $ MILLION)
FIGURE
3: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND
ACCESSORIES, 2024-2032 (IN $ MILLION)
FIGURE
4: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES,
2024-2032 (IN $ MILLION)
FIGURE
5: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY TYPE, 2023 & 2032 (IN %)
FIGURE
6: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX
ASSAY, 2024-2032 (IN $ MILLION)
FIGURE
7: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED
MULTIPLEX ASSAY, 2024-2032 (IN $ MILLION)
FIGURE
8: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY OTHER MULTIPLEX ASSAYS,
2024-2032 (IN $ MILLION)
FIGURE
9: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2023 &
2032 (IN %)
FIGURE
10: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT,
2024-2032 (IN $ MILLION)
FIGURE
11: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS,
2024-2032 (IN $ MILLION)
FIGURE
12: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS,
2024-2032 (IN $ MILLION)
FIGURE
13: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2023 &
2032 (IN %)
FIGURE
14: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN
MICROARRAY, 2024-2032 (IN $ MILLION)
FIGURE
15: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2024-2032
(IN $ MILLION)
FIGURE
16: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGIES,
2024-2032 (IN $ MILLION)
FIGURE
17: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICAL, 2023
& 2032 (IN %)
FIGURE
18: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL &
BIOTECHNOLOGY COMPANIES, 2024-2032 (IN $ MILLION)
FIGURE
19: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES,
2024-2032 (IN $ MILLION)
FIGURE
20: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES,
2024-2032 (IN $ MILLION)
FIGURE
21: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2024-2032 (IN
$ MILLION)
FIGURE
22: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2023
& 2032 (IN %)
FIGURE
23: UNITED ARAB EMIRATES MULTIPLEX ASSAYS MARKET, 2024-2032 (IN $ MILLION)
FIGURE
24: SAUDI ARABIA MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)
FIGURE
25: TURKEY MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)
FIGURE
26: SOUTH AFRICA MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)
FIGURE
27: REST OF MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET 2024-2032 (IN $
MILLION)